Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2024

May 23, 2024

34129_dirs_2024-05-23_9d046ce5-49c5-4f35-b6ac-b8ebd07f3cbb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2024-05-21

Reporting Person: O'Brien Federica F. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-05-21 Restricted Stock Unit $0 A 6500 Acquired Common Stock (6500) Direct
2024-05-21 Stock Option (right to buy) $4.26 A 16500 Acquired 2034-05-21 Common Stock (16500) Direct

Footnotes

F1: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2: The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

F3: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.